NovoCure Ltd (N2VC34)
BOV
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-06-04 | Mr. Frank LeonardCEO & Director | -34.27k | 614.63k | 売り | 17.93 | 149.07k | -18.69% |
| 2026-06-02 | Mr. Kinyip Gabriel LeungIndependent Director | -2.95k | 46.44k | 売り | 15.77 | 89.50k | -3.19% |
| 2026-06-02 | Dr. Allyson J. OceanIndependent Director | -2.95k | 46.44k | 売り | 15.77 | 11.32k | -20.64% |
| 2026-06-02 | Ms. Kristin StaffordIndependent Director | -2.95k | 46.44k | 売り | 15.77 | 11.32k | -20.64% |
| 2026-06-02 | Ms. Jeryl Lynn HillemanIndependent Director | -2.95k | 46.44k | 売り | 15.77 | 13.86k | -17.52% |
| 2026-06-02 | Mr. Timothy John ScannellIndependent Director | -2.95k | 46.44k | 売り | 15.77 | 14.29k | -17.09% |
| 2026-06-02 | Dr. David T. HungIndependent Director | -2.95k | 46.44k | 売り | 15.77 | 20.47k | -12.58% |
| 2026-06-02 | Mr. William Anthony VernonLead Independent Director | -2.95k | 46.44k | 売り | 15.77 | 197.66k | -1.47% |
| 2026-04-28 | Mr. William Anthony VernonLead Independent Director | 21.50k | 244.89k | Derivative Exercise and Retained Stock | 11.39 | 200.60k | 12.00% |
| 2026-03-04 | Dr. Nicolas Leupinインサイダー | -1.10k | 14.64k | 売り | 13.31 | 30.96k | -3.43% |
| 2026-03-04 | Ms. Ashley Cordovaインサイダー | -17.64k | 234.59k | Sale to Issuer | 13.30 | 422.57k | -4.01% |
| 2026-03-04 | Dr. Uri WeinbergChief Innovation Officer & Chief Medical Officer | -6.41k | 85.31k | 売り | 13.31 | 153.15k | -4.02% |
| 2026-03-04 | Mr. Frank LeonardCEO & Director | -5.61k | 74.60k | 売り | 13.31 | 93.63k | -5.65% |
| 2026-03-04 | Mr. Christoph BrackmannCFO | -6.41k | 85.31k | 売り | 13.31 | 50.87k | -11.19% |
| 2026-03-03 | Mr. William F. DoyleExecutive Chairman | -71.89k | 932.88k | 売り | 12.79 - 13.43 | 128.40k | -35.89% |
| 2026-03-04 | Mr. Mukund ParavasthuCOO | -48.62k | 667.21k | 売り | 13.31 - 13.77 | 72.83k | -40.03% |
| 2026-03-04 | Mr. Michael PuriChief HR Officer | -1.10k | 14.64k | 売り | 13.31 | 88.18k | -1.23% |
| 2026-02-27 | Dr. Uri WeinbergChief Innovation Officer & Chief Medical Officer | -10.73k | 146.86k | 売り | 13.33 - 13.84 | 141.24k | -7.06% |
| 2026-02-27 | Mr. Mukund ParavasthuCOO | -1.96k | 26.75k | 売り | 13.49 - 13.66 | 76.34k | -2.51% |
| 2026-02-27 | Mr. Frank LeonardCEO & Director | -16.97k | 230.58k | 売り | 13.49 - 13.66 | 80.92k | -17.33% |
| 2026-02-27 | Mr. Michael PuriChief HR Officer | -1.44k | 19.69k | 売り | 13.66 | 70.96k | -1.99% |
| 2026-02-27 | Dr. Nicolas Leupinインサイダー | -1.03k | 14.06k | 売り | 13.66 | 32.06k | -3.11% |
| 2026-02-27 | Ms. Ashley Cordovaインサイダー | -21.18k | 290.44k | Sale to Issuer | 13.67 - 13.75 | 254.94k | -7.67% |
| 2026-01-11 | Mr. Mukund ParavasthuCOO | -2.13k | 30.61k | Sale to Issuer | 14.35 | 78.31k | -2.65% |
| 2025-11-01 | Mr. Mukund ParavasthuCOO | -3.12k | 38.22k | Sale to Issuer | 12.23 - 12.81 | 80.44k | -3.73% |
| 2025-11-04 | Mr. Christoph BrackmannCFO | -7.03k | 86.01k | Sale to Issuer | 12.23 | 38.96k | -15.29% |
| 2025-10-31 | Mr. Michael PuriChief HR Officer | -752.00 | 9.64k | Sale to Issuer | 12.82 | 48.54k | -1.53% |
| 2025-11-01 | Mr. Frank LeonardCEO & Director | -966.00 | 12.37k | Sale to Issuer | 12.81 | 38.97k | -2.42% |
| 2025-09-05 | Ms. Ashley Cordovaインサイダー | 81.55k | 996.86k | 買い | 12.22 | 210.28k | 63.35% |
| 2025-07-29 | Mr. Christoph BrackmannCFO | 20.00k | 231.80k | 買い | 11.50 - 11.63 | 25.90k | 339.10% |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。